Key Trends Fueling the Boom in Genetic Testing: Industry Research Report

Key Trends Fueling the Boom in Genetic Testing

Published Date: June 2009

Published By: Decision Resources

Order Code: R55-651

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Executive Summary: Strategic Considerations; Stakeholder Implications
Introduction
Connecting the Dots: Gene to Disease: Genetic Variation Is Key to Novel Developments; Potential to Address Broader Unmet Needs
Individualizing Personal Genomics
Rekindling Pharmacogenomics
Personalized Medicine as a Driver for Growth: Targeted Therapies and Companion Diagnostics; Fueling Interest in Other Therapy Areas; Turning Yesterday’s Failures into Today’s Personalized Medicine Success Stories
Creating Sustainable Growth in the Field: Refine Next-Generation Sequencing Technologies; Correctly Navigate the Approval Process; Capitalize on Recent Legislative Support; Effectively Engage Payers for Novel Tests; Push for Large-Scale Genomic Studies; Gracefully Ride Out the Economic Crisis
Conclusions
Expert Commentaries: Finding Value in Genetic Testing; A Perspective on Approval Strategies for Gene-Based Companion Diagnostics; Keith F. Batchelder, M.D., CEO and Founder, Genomic Health Care Strategies.
Sidebar: Impact of the Economic Crisis on Emerging Diagnostics Companies
Tables: 1. Select Genetic Testing Companies; 2. Select Prenatal Diagnostic Tests for Genetic Analysis; 3. Select Findings from Recent Genetic Variation Studies; 4. Select Personal Genomics Services and Costs; 5. Select Gene-Based Companion Diagnostic Tests for Breast Cancer; 6. Targeted Therapies for Which Genetic Testing May Be Useful to Guide Prescribing; 7. Select Genetic Companion Diagnostic Tests and Associated Therapeutics; 8. Select Large-Scale Genetic Variation Studies
Figures: 1. Potential Market Impact by Select Companies That Offer Novel Prenatal Diagnostics; 2. Teams Competing for Archon X Prize for Genomics